 | • レポートコード：D0-MOR-AP1102 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、構造生物学及び分子モデリング技術の世界市場について調査・分析した資料で、構造生物学及び分子モデリング技術の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Structural Biology and Molecular Modeling Techniques market studied is anticipated to grow with a CAGR of nearly 10.4%, during the forecast period.
Certain factors that are driving the market growth include technological innovations and advancements, and rising prevalence of chronic diseases.
3D modeling software is a powerful tool that helps many professionals create complex 3D graphics and visualize their work. In the field of structural biology and biochemistry, there are various software for molecular modeling and visualization. Some chemistry software are better in terms of drawing chemical reactions, some others find better applications in the simulation of protein structures.
Key Market Trends
Drug development Holds Significant Market Share in the Global Structural Biology and Molecular Modeling Techniques Market
The propelling factors for the growth of the drug discovery market include the rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.
The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence, globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and its burden, globally, drives the demand for drug discovery and its market.
There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics and combinatorial chemistry for better drug candidate identification.
North America Dominates the Global Structural Biology and Molecular Modeling Techniques Market
North America dominates the market and incurs the highest expenditure for global R&D. The United States accounted for the largest share in 2019. The North America segment is on a rise, due to various ongoing researches in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of structural biology and molecular modeling techniques in the market. Owing to the ongoing research and outsourcing activities in the field of life science, Asia-Pacific also has lucrative opportunities for growth over the forecast period.
Competitive Landscape
The global Structural Biology and Molecular Modeling Techniques market is competitive and consists of a number of major players. Companies like Acellera Ltd., Agile Molecule, Agilent Technologies, Inc., Biomax Informatics AG, Bruker Daltonics Inc., Chemical Computing Group, Dassault Systèmes, Illumina, ThermoFisher Scientific, among others, hold the substantial market share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Innovations and Advancements
4.2.2 Rising Prevalence of Chronic Diseases
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Tools
5.1.1 SaaS & standalone modeling
5.1.1.1 Homology modeling
5.1.1.2 Threading
5.1.1.3 Molecular dynamics
5.1.1.4 Others
5.1.2 Visualization & analysis
5.1.3 Others
5.2 By Application
5.2.1 Drug Development
5.2.2 Drug Discovery
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Acellera Ltd.
6.1.2 Agile Molecule
6.1.3 Agilent Technologies, Inc.
6.1.4 Biomax Informatics AG
6.1.5 Bruker Daltonics Inc.
6.1.6 Chemical Computing Group
6.1.7 Dassault Systemes
6.1.8 Illumina
6.1.9 ThermoFisher Scientific
7 MARKET OPPORTUNITIES AND FUTURE TRENDS